Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Promote FHACT(TM) Test for Cervical Cancer at American Congress of Obstetricians and Gynecologists' Annual Clinical Meeting

RUTHERFORD, N.J., April 25, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, will be participating in the...
April 10, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics CEO Moderates Panel Discussion With Thought Leaders in Biopharma at the BioNJ 2014 International BioPartnering Conference

Panna Sharma, CEO of Cancer Genetics, Is Moderating a Panel Entitled "Partnering for a Balanced Portfolio: Perspectives from Innovators, Partners, & Payers" RUTHERFORD, N.J., April 10,...
April 04, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms

New Test Launch Extends CGI's Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI's Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4,...
April 03, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACR

RUTHERFORD, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of...
March 26, 2014 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Results, Provides Corporate Update

72% Year-Over-Year Revenue Growth During Fourth Quarter 2013 54% Full Year 2013 Revenue Growth Achieving $6.6 Million For 2013 Gross Margins Increased Threefold to 25.5% for Full Year...
March 21, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Report Fourth Quarter and Year-End 2013 Results on Wednesday, March 26, 2014

RUTHERFORD, N.J., March 21, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, announced today that it will report its...
March 20, 2014 08:00 ET | Source: Cancer Genetics, Inc.

CGI's Proprietary DNA-Based Test for Cervical Cancer, FHACT(TM), Adopted by Leading Kamineni Hospital Group in India for the Diagnosis and Triaging of Cervical Cancer

There are over 123,000 new cervical cancer cases in India each year where it is a leading cause of cancer mortality, causing 17% of deaths in women 30-69 years of age. ...
March 17, 2014 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Appoints Edward J. Sitar as Chief Financial Officer

RUTHERFORD, N.J., March 17, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that effective April 1, 2014, it has appointed Edward...
March 05, 2014 08:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Compelling Diagnostic Sensitivity (99%) and Accuracy (93%) for Its Patent-Protected Genomic Kidney Cancer Test

93% Diagnostic Accuracy and 99% Specificity Support Implementation of the CGI Kidney Cancer Algorithm and Test in A Clinical Setting New Data Presented at USCAP Annual Meeting; 188 Patient...
February 26, 2014 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Adds Additional Kidney Cancer Patent to its Portfolio

RUTHERFORD, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced that the United States...